|1.||Sousa, Norma C: 1 article (09/2014)|
|2.||Smaal, Adriana: 1 article (09/2014)|
|3.||Rennó, André L: 1 article (09/2014)|
|4.||Hyslop, Stephen: 1 article (09/2014)|
|5.||Dias, Lourdes: 1 article (09/2014)|
|6.||Rodrigues, Mariana A P: 1 article (09/2014)|
|7.||da Silva, Delano A: 1 article (09/2014)|
|8.||de Araujo, Elizabeth Giestal: 1 article (03/2011)|
|9.||da Silva Cunha, Karinne Cristinne: 1 article (03/2011)|
|10.||Fuly, André Lopes: 1 article (03/2011)|
01/01/1997 - "Under hypoxia, the PLA2 inhibitor bromophenacyl bromide (BPB) inhibited AA release and PGF2 alpha synthesis, yet it did not affect the increase in glucose uptake into L6 myotubes. "
06/26/1998 - "Phospholipase inhibition with quinacrine, 4-bromophenacyl bromide and 7,7-dimethyl-eicosadenoic acid (DEDA) depressed the anoxia-evoked release of amino acids. "
08/15/1984 - "The mitochondrial dysfunction induced by anoxia in vitro was improved with chlorpromazine, cepharanthine, bromophenacyl bromide, and mepacrine without affecting phospholipid or adenine nucleotide metabolisms. "
12/14/2001 - "Indeed, the secretory PLA2 (sPLA2) inhibitor 4-bromophenacyl bromide diminishes both delayed lysosomal rupture and apoptosis. "
01/01/2008 - "Furthermore, oenocytoids exposed to eicosanoid biosynthesis inhibitors such as dexamethasone and bromophenacyl bromide showed significant reduction in cell rupture. "
08/06/1990 - "Indeed, when the esterase activity of basic phospholipase A2 was eliminated by treatment with p-bromophenacyl bromide, the enzyme retained a cytotoxic potency inducing necrosis of certain tumoral cells grown in vitro, but not other cells such as erythrocytes, for which concomitant esterase activity was also necessary. "
06/01/1993 - "To eliminate the possibility that the necrosis was due to contaminating phospholipase A2 (PLA2) activity of the sample, the sample was treated with p-bromophenacyl bromide (p-BPB), a known inhibitor of PLA2 activity. "
11/01/1984 - "Human spermatozoa were preincubated for 4 hr in modified Biggers, Whitten, and Whittingham's medium (mBWW) containing a specific phospholipase A2 inhibitor, p-bromophenacyl bromide (p-BPB: 1 X 10(-5) - 1 X 10(-3) M), lysophosphatidyl choline (LC: 5-500 micrograms/ml), and arachidonic acid (AA: 5-500 micrograms/ml), prior to the addition of zona-free superovulated hamster eggs. "
06/01/1985 - "For this study, we examined the effects of Ca++, Mg++, Kallikrein, Phospholipase A2, p-bromophenacyl bromide (Phospholipase A2 specific inhibitor), Lysophosphatidyl choline, Arachidonic acid, and Glyceryl monooleate using in vitro penetration assay employing zona- free hamster eggs. "
01/01/1984 - "In this study the effect of p-bromophenacylbromide (p-BPAB), an inhibitor of phospholipase A, was studied in acute pancreatitis in an experimental rat model. "
01/01/1984 - "[The effect of p-bromophenacylbromide, a phospholipase A inhibitor, in experimental acute pancreatitis in rats]."
|1.||Phospholipases A2 (Phospholipase A2)
|9.||Choline (Choline Chloride)
|10.||Arachidonic Acid (Vitamin F)